Pharmaceutical / Drug Definition :
Blocks alpha1-adrenergic receptors, promoting vasodilation. Also reduces urethral resistance, relieving obstruction and improving urine flow and other symptoms of benign prostatic hypertrophy (BPH).
In the United States, Doxazosin Mesylate is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Doxazosin Mesylate.
FDA Label Requirements and Exceptions
FDA Import Information
Doxazosin Mesylate (Doxazosin Mesylate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Doxazosin Mesylate (Doxazosin Mesylate Suppliers)
- Processors Doxazosin Mesylate
- Repackers Doxazosin Mesylate
- Relabelers Doxazosin Mesylate
- Exporters Doxazosin Mesylate
- Importers Doxazosin Mesylate
For more information about Doxazosin Mesylate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.